A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs.
from NYT > Health https://ift.tt/2CymcNw
via health&fitness
Aucun commentaire:
Enregistrer un commentaire